{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:21:54Z","timestamp":1792160514352,"version":"4.4.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Solid organ transplant (SOT) recipients are at high risk for severe respiratory syncytial virus (RSV). While RSV vaccine immunogenicity data in transplant populations are emerging, questions remain regarding the magnitude and durability of responses, cellular immunity, and determinants of decreased response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We conducted a prospective, single-center cohort study evaluating RSV vaccine reactogenicity and immunogenicity in SOT recipients compared with healthy controls. Serum was collected pre-vaccination and at 1, 3, and 6 mo post-vaccine to measure anti-fusion glycoprotein antibodies to RSV A and B and anti-nucleocapsid antibodies as a marker of natural infection. Peripheral blood mononuclear cells were collected from a subset for RSV-fusion (F)-specific cellular analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Forty-three SOT recipients (median age, 65) and 16 controls were enrolled (from October 2023 to January 2024). Mild reactogenicity occurred in ~25% of participants, with no severe events. In SOT recipients, anti-fusion glycoprotein IgG, RSV-F-specific CD4\n                      <jats:sup>+<\/jats:sup>\n                      and CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells increased significantly at 1 mo (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.01), with similar antibody fold changes to controls. Antibody responses remained durable through 6 mo; the rate of decline did not differ significantly between groups. Mycophenolate use was inversely correlated with antibody titers (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u20050.05); vaccine type, organ, and time from transplant were not. The adjuvanted vaccine induced greater RSV-F-specific CD4\n                      <jats:sup>+<\/jats:sup>\n                      T-cell responses at 3 mo. One SOT recipient developed RSV during the study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>RSV vaccination was well tolerated and immunogenic in SOT recipients. Further research should optimize vaccination strategies and ideal timing for booster doses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001977","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:00:13Z","timestamp":1784584813000},"page":"e1977","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Reactogenicity and Immunogenicity of Adjuvanted and Nonadjuvanted RSV Vaccines in Solid Organ Transplant Recipients"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-9820","authenticated-orcid":false,"given":"Alisse","family":"Hannaford","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elene","family":"Chamberlin","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Swank","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Broad Institute of MIT & Harvard, Cambridge, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon D.","family":"van Haren","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samual","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Broad Institute of MIT & Harvard, Cambridge, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanya","family":"Thomas","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Thoracic Surgery, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ryff","sequence":"additional","affiliation":[{"name":"Precision Vaccines Program, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Connolly","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella N.","family":"Woehl","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Regan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"Valentine","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Morreale","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Eustace","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tong","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Lan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Walt","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Wyss Institute for Biologically Inspired Engineering, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Levy","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Broad Institute of MIT & Harvard, Cambridge, MA."},{"name":"Precision Vaccines Program, Department of Pediatrics, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas C.","family":"Issa","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal S.","family":"Sharma","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Pulmonary, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep R.","family":"Mehra","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Givertz","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Tullius","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Transplant Surgery, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil R.","family":"Azzi","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Renal Medicine, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Coppolino","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Boston, MA."},{"name":"Division of Thoracic Surgery, Brigham and Women\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Baden","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Sherman","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2810-1618","authenticated-orcid":false,"given":"Ann E.","family":"Woolley","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, MA."},{"name":"Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"R1-20260720","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12879-018-3002-3","article-title":"Burden of severe RSV disease among immunocompromised children and adults: a 10 year retrospective study.","volume":"18","author":"Chatzis","year":"2018","journal-title":"BMC Infect Dis"},{"key":"R2-20260720","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-2007-976494","article-title":"Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.","volume":"28","author":"Kim","year":"2007","journal-title":"Semin Respir Crit Care Med"},{"key":"R3-20260720","doi-asserted-by":"crossref","first-page":"e13511","DOI":"10.1111\/ctr.13511","article-title":"RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.","volume":"33","author":"Manuel","year":"2019","journal-title":"Clin Transplant"},{"key":"R4-20260720","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.3949\/ccjm.91.s1.06","article-title":"RSV in transplant and immunocompromised patients.","volume":"91","author":"Koval","year":"2024","journal-title":"Cleve Clin J Med"},{"key":"R5-20260720","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cmi.2020.07.050","article-title":"Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study.","volume":"27","author":"Testaert","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"R6-20260720","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults.","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"R7-20260720","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults.","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"R8-20260720","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3390\/vaccines11030672","article-title":"RSV A2-based prefusion F vaccine candidates induce RSV A and RSV B cross binding and neutralizing antibodies and provide protection against RSV A and RSV B challenge in preclinical models.","volume":"11","author":"Cox","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"R9-20260720","doi-asserted-by":"crossref","first-page":"e13772","DOI":"10.1111\/tid.13772","article-title":"Humoral and cellular immune responses to the SARS-CoV-2 BNT162b2 vaccine among a cohort of solid organ transplant recipients and healthy controls.","volume":"24","author":"Yanis","year":"2022","journal-title":"Transpl Infect Dis"},{"key":"R10-20260720","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/cid\/ciad477","article-title":"Immunogenicity of high-dose versus MF59-adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the Swiss\/Spanish trial in solid organ transplantation on prevention of influenza (STOP-FLU trial).","volume":"78","author":"Mombelli","year":"2024","journal-title":"Clin Infect Dis"},{"key":"R11-20260720","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations.","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"key":"R12-20260720","doi-asserted-by":"crossref","first-page":"e226822","DOI":"10.1001\/jamanetworkopen.2022.6822","article-title":"Immunogenicity and risk factors associated with poor humoral immune response of SARS-CoV-2 vaccines in recipients of solid organ transplant: a systematic review and meta-analysis.","volume":"5","author":"Manothummetha","year":"2022","journal-title":"JAMA Netw Open"},{"key":"R13-20260720","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/ajt.16710","article-title":"Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: not alarming, but should be taken gravely.","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"R14-20260720","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients.","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"R15-20260720","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1111\/ajt.16766","article-title":"Humoral and cellular immune response and safety of two-dose SARS-CoV-2 mRNA-1273 vaccine in solid organ transplant recipients.","volume":"21","author":"Hall","year":"2021","journal-title":"Am J Transplant"},{"key":"R16-20260720","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cmi.2025.09.013","article-title":"Safety and immunogenicity of adjuvanted respiratory syncytial virus vaccine in high-risk transplant recipients: an interventional cohort study.","volume":"32","author":"Hall","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"R17-20260720","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.ajt.2025.03.025","article-title":"Respiratory syncytial virus prefusion F3 vaccine in lung transplant recipients elicits CD4+ T cell response in all vaccinees.","volume":"25","author":"Havlin","year":"2025","journal-title":"Am J Transplant"},{"key":"R18-20260720","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/jama.2024.25395","article-title":"Antibody response to respiratory syncytial virus vaccination in immunocompromised persons.","volume":"333","author":"Karaba","year":"2025","journal-title":"JAMA"},{"key":"R19-20260720","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41551-020-00611-x","article-title":"Ultrasensitive high-resolution profiling of early seroconversion in patients with COVID-19.","volume":"4","author":"Norman","year":"2020","journal-title":"Nat Biomed Eng"},{"key":"R20-20260720","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1038\/s41467-024-47757-9","article-title":"Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic.","volume":"15","author":"Rios-Guzman","year":"2024","journal-title":"Nat Commun"},{"key":"R21-20260720","doi-asserted-by":"crossref","first-page":"ofac417","DOI":"10.1093\/ofid\/ofac417","article-title":"Immunogenicity of a three-dose primary series of mRNA COVID-19 vaccines in patients with lymphoid malignancies.","volume":"9","author":"Sherman","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"R22-20260720","doi-asserted-by":"crossref","first-page":"126054","DOI":"10.1016\/j.vaccine.2024.05.081","article-title":"Heterologous SARS-CoV-2 booster vaccine for individuals with hematological malignancies after a primary SARS-CoV-2 mRNA vaccine series.","volume":"42","author":"Sherman","year":"2024","journal-title":"Vaccine"},{"key":"R23-20260720","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajt.2025.09.023","article-title":"Cellular and humoral immunogenicity of respiratory syncytial virus vaccination in solid organ transplant recipients.","volume":"26","author":"Bronder","year":"2026","journal-title":"Am J Transplant"},{"key":"R24-20260720","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3390\/vaccines13040398","article-title":"Neutralizing antibody response to the AreXvy respiratory syncytial virus vaccine in lung transplant recipients: assessment against reference and seasonal strains.","volume":"13","author":"Levy","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"R25-20260720","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"R26-20260720","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3390\/vaccines13030328","article-title":"Immunogenicity and safety of the bivalent respiratory syncytial virus prefusion F subunit vaccine in immunocompromised or renally impaired adults.","volume":"13","author":"Almeida","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"R27-20260720","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1038\/s41591-021-01507-2","article-title":"Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy.","volume":"27","author":"Apostolidis","year":"2021","journal-title":"Nat Med"},{"key":"R28-20260720","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.2022016175","article-title":"Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.","volume":"140","author":"Atanackovic","year":"2022","journal-title":"Blood"},{"key":"R29-20260720","doi-asserted-by":"crossref","first-page":"e180667","DOI":"10.1172\/jci.insight.180667","article-title":"Preservation of naive-phenotype CD4+ T cells after vaccination contributes to durable immunity.","volume":"9","author":"Pan","year":"2024","journal-title":"JCI Insight"},{"key":"R30-20260720","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1177\/10600280241241049","article-title":"Vaccines for respiratory syncytial virus prevention in older adults.","volume":"58","author":"Wroblewski","year":"2024","journal-title":"Ann Pharmacother"},{"key":"R31-20260720","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/pathogens15010005","article-title":"Peptide MegaPools approach to evaluate the dengue-specific CD4 and CD8 T-cell response.","volume":"15","author":"Tiberi","year":"2025","journal-title":"Pathogens"},{"key":"R32-20260720","article-title":"Prediction of SARS-CoV-2 exposure through T cell activation profiles.","author":"Van de Bittner","journal-title":"Sci Rep"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T22:00:17Z","timestamp":1784584817000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":32,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001977","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"2026-03-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}